NEWS AND VIEWS FROM THE PHARMACEUTICAL FINE CHEMICAL AND CUSTOM MANUFACTURING SECTOR

Thursday 10 January 2008

Teva invests

Teva is undertaking a $1bn expansion programme in India. Initially, the company plans to use $250m-$300m to build new generic ingredients manufacturing facilities. The first of these is a large API manufacturing facility Gwalior, Madhya Pradesh.
In-Pharma Technologist

No comments: